Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Piramal Enterprises Ltd    PEL   INE140A01024

PIRAMAL ENTERPRISES LTD (PEL)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
11/14/2017 11/15/2017 11/16/2017 11/17/2017 11/20/2017 Date
2628.1(c) 2562(c) 2582.6(c) 2588(c) 2609.3 Last
94 442 89 961 85 609 69 753 104 617 Volume
+0.26% -2.52% +0.80% +0.21% +0.82% Change
More quotes
Financials ( INR)
Sales 2018 111 B
EBIT 2018 37 846 M
Net income 2018 -
Debt 2018 -
Yield 2018 1,08%
Sales 2019 136 B
EBIT 2019 47 422 M
Net income 2019 -
Debt 2019 -
Yield 2019 1,37%
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 4,04x
Capi. / Sales2019 3,31x
Capitalization 448 B
More Financials
Company
Piramal Enterprises Ltd. engages in pharmaceutical business with its research and development activities.The company operates through the following segments: Pharmaceuticals Manufacturing and Services, Financial Services, and Information Management.The Pharmaceuticals Manufacturing and Services... 
Sector
Pharmaceuticals
Calendar
01/30Earnings Release
More about the company
Latest news on PIRAMAL ENTERPRISES LTD
11/08 Contract Pharmaceutical Manufacturing Global Market Outlook – Productio..
11/07 PIRAMAL ENTERPRISES : Q2 net rises 25%
10/25 PIRAMAL ENTERPRISES : announces allotment of 4.6 Lakh CCDs
10/23 PIRAMAL ENTERPRISES : unveils educational game for children
10/14 PIRAMAL ENTERPRISES : board approves rights issue and merger plan
10/11 PIRAMAL ENTERPRISES : to invest $55 million in API capacity expansion
10/11 PIRAMAL ENTERPRISES : invests $55 million to upgrade API plants
10/10 PIRAMAL ENTERPRISES : Pharma Solutions Announces Large scale Expansion of API Ma..
10/05 PIRAMAL ENTERPRISES : FINANCE SANCTIONS Rs280 CRORE
10/04 PIRAMAL ENTERPRISES : Finance sanctions Rs. 280 crores to Puranik Builders
More news
Sector news : Pharmaceuticals - NEC
12:24pDJROCHE : Shares Rise on Positive Results From Clinical Trials
10:25a German losses keep European shares flat as govt talks collapse
08:19aDJNOVARTIS : Secures EU Approval for Tasigna Treatment in Children
11/18DJADRs End Higher; JA Solar, NetEase Trade Actively
11/17 British stocks fall back as Carillion crashes, Sky soars
More sector news : Pharmaceuticals - NEC
Chart PIRAMAL ENTERPRISES LTD
Duration : Period :
Piramal Enterprises Ltd Technical Analysis Chart | PEL | INE140A01024 | 4-Traders
Technical analysis trends PIRAMAL ENTERPRISES LTD
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 3 058  INR
Spread / Average Target 18%
Managers
NameTitle
Khushru Burjor Jijina Managing Director
Ajay Gopikisan Piramal Chairman
Vijay Kantilal Shah Chief Operating Officer & Executive Director
Swati Ajay Piramal Vice Chairman
Subramanian V. Ramadorai Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
PIRAMAL ENTERPRISES LTD58.15%6 896
JOHNSON & JOHNSON19.78%370 740
NOVARTIS11.20%219 321
PFIZER8.90%210 830
ROCHE HOLDING LTD.-1.55%200 193
MERCK AND COMPANY-6.23%150 550